International Vaccine Institute
Seoul, Korea, Republic of
Purpose
To generate long term immunogenicity data of the Hecolin® vaccine in phase 2b follow-up study in South Africa.
Division
Global Health
Date
January 2025
Region Served
AFRICA
Committed amount
$2,961,068
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
31
Grantee location
Seoul, Korea, Republic of
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.